DNA Replication Checkpoint in Fission Yeast
裂殖酵母中的 DNA 复制检查点
基本信息
- 批准号:10557924
- 负责人:
- 金额:$ 37.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAntineoplastic AgentsAreaBiochemicalCell DeathCellsChemotherapy-Oncologic ProcedureCollectionComplexDNA biosynthesisDNA replication forkDNA-Directed DNA PolymeraseDataDefectEukaryotaFission YeastGeneticGenome StabilityGenomic InstabilityGoalsHumanIn VitroKnowledgeMalignant NeoplasmsMammalian CellMethodsMolecularMonitorMutationPathway interactionsPhosphotransferasesProcessProteinsPublic HealthPublishingResearchS phaseSignal PathwaySignal TransductionStressStudy modelsWorkanti-cancerdisorder preventionforward geneticshelicaseimprovedin vivomutantpreventprogramsprotein purificationreconstitutionreplication stressresponsesensortumorigenesis
项目摘要
PROJECT SUMMARY/ABSTRACT .
DNA replication checkpoint is a cell signaling pathway operating in all eukaryotes that monitors normal S phase
progression and in response to perturbed DNA replication, activates cellular responses to prevent irreversible
replication fork arrest, genomic instability, and cell death. The checkpoint senses the perturbed replication,
maintains the genomic stability under stress and thus functions as an important anticancer barrier. Many
anticancer drugs work by interfering with DNA replication and their efficacy is therefore influenced by the
checkpoint status of cancer. Despite its importance in disease prevention and cancer chemotherapies, we still
do not fully understand the checkpoint initiation process at the replication forks, nor do we know exactly how the
checkpoint protects the fork functions under stress. As an established model for studying the cellular
mechanisms that are conserved in humans, fission yeast offers several benefits for this research. The goal of
this project is to investigate the newly screened checkpoint mutants in fission yeast with particular emphasis on
two objectives: (1) understand the mechanistic underpinnings of checkpoint initiation at the perturbed forks, and
(2) uncover the essential molecular details of the checkpoint-regulated fork protection. As a starting point, we
have developed a combined approach of forward genetics and biochemical analysis and have identified several
new mutants with various checkpoint initiation defects under replication stress. We have also screened a large
collection of mutants that are defective in fork protection. Guided by our strong preliminary and published data,
we will conduct in vivo and in vitro studies under the first objective to investigate how the checkpoint sensor
kinase Rad3(ATR) signaling is affected by mutations in the Rad3-Rad26 complex, the RecQ helicase Rqh1, the
Smc5/6 complex, and the RPA complex. Under the second objective, we will investigate how the activated
checkpoint regulates DNA polymerase e on the leading strand and other yet-to-be identified targets for fork
protection. The long-term goal of this research program is to provide a comprehensive understanding of the
replication checkpoint that involves three primary areas of inquiry: First, by using our newly improved genetic
method, replication proteins with conserved checkpoint functions will be identified. Second, reconstitution of the
checkpoint pathway in vitro using purified proteins that can properly recapitulate the in vivo data we and others
have obtained. Third, as we show in the studies on Rqh1, conservation of the checkpoint mechanisms in human
cells will be evaluated. Overall, this research program will bring much improved clarity to the molecular
mechanisms of the replication checkpoint in fission yeast as well as in mammalian cells. The proposed research
is significant because of its relevance to genome instability, oncogenesis, and cancer chemotherapies.
项目摘要/摘要。
DNA复制检查点是在所有真核生物中运行的细胞信号通路
进展并响应扰动的DNA复制,激活细胞反应以防止不可逆
复制叉停滞,基因组不稳定性和细胞死亡。检查点感知扰动的复制,
在应力下保持基因组稳定性,从而充当重要的抗癌屏障。许多
抗癌药物通过干扰DNA复制而起作用,因此其功效受到
癌症的检查点状态。尽管它在预防疾病和癌症化学疗法方面具有重要意义,但我们仍然
请勿完全了解复制叉处的检查点启动过程,我们也不确切知道如何
检查点在压力下保护叉功能。作为研究细胞的既定模型
裂变酵母在人类中保守的机制为这项研究提供了一些好处。目标
该项目是为了调查裂变酵母中新筛选的检查点突变体,特别强调
两个目标:(1)了解扰动叉子的检查点启动的机械基础,以及
(2)揭示了检查点调节的叉子保护的基本分子细节。作为起点,我们
已经开发了远期遗传学和生化分析的联合方法,并确定了几个
在复制应力下具有各种检查点起始缺陷的新突变体。我们还筛选了一个大的
集合在叉子保护中有缺陷的突变体。在我们强大的初步和公开数据的指导下,
我们将在第一个目标下进行体内和体外研究,以研究检查点传感器
激酶RAD3(ATR)信号传导受Rad3-Rad26复合物中突变的影响,RECQ旋转酶RQH1,
SMC5/6复合物和RPA复合物。在第二个目标下,我们将研究如何激活
检查点在领先链和其他尚未确定的叉子上调节DNA聚合酶E
保护。该研究计划的长期目标是提供对
复制检查点,涉及三个主要查询领域:首先,使用我们新的遗传
方法,将确定具有保守检查点功能的复制蛋白。其次,重组
使用纯化的蛋白质在体外进行检查点途径,该蛋白可以正确概括我们和其他人的体内数据
已经获得了。第三,正如我们在RQH1的研究中所显示的那样,人类检查点机制的保存
将评估细胞。总体而言,该研究计划将为分子带来很大的清晰度
裂变酵母以及哺乳动物细胞中复制检查点的机制。拟议的研究
由于与基因组不稳定性,肿瘤发生和癌症化学疗法的相关性而具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yongjie Xu其他文献
Yongjie Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yongjie Xu', 18)}}的其他基金
Signaling Mechanism of the DNA Replication Checkpoint
DNA 复制检查点的信号传导机制
- 批准号:
9001349 - 财政年份:2015
- 资助金额:
$ 37.5万 - 项目类别:
Signaling Mechanism of the DNA Replication Checkpoint
DNA 复制检查点的信号传导机制
- 批准号:
9695226 - 财政年份:2015
- 资助金额:
$ 37.5万 - 项目类别:
Signaling Mechanism of the DNA Replication Checkpoint
DNA 复制检查点的信号传导机制
- 批准号:
8818250 - 财政年份:2015
- 资助金额:
$ 37.5万 - 项目类别:
相似国自然基金
基于脱氢弯孢霉素骨架的ACLY降解剂的设计、合成及抗肿瘤活性研究
- 批准号:82304312
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于阳离子-π相互作用的“开/关”型纳米光敏剂的光敏活性调控及其抗肿瘤研究
- 批准号:82304434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载自组装型非核苷类STING激动剂的亚精胺水凝胶用于抗肿瘤免疫治疗及机制研究
- 批准号:82303561
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于PROTAC的选择性AKT1降解剂的设计、合成及抗肿瘤活性研究
- 批准号:82304287
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于PWWP域的NSD2蛋白降解剂的设计、合成与抗肿瘤活性研究
- 批准号:22307132
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Clinical biomarker for early prediction of chemotherapy-induced peripheral neuropathy
早期预测化疗引起的周围神经病变的临床生物标志物
- 批准号:
10604018 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10589265 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment
癌细胞选择性杀伤纳米颗粒用于晚期卵巢癌治疗
- 批准号:
10680585 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
Mechanisms and dynamics of allosteric function in proteins
蛋白质变构功能的机制和动力学
- 批准号:
10653812 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别: